Advertisement

Reactions Weekly

, Volume 1731, Issue 1, pp 142–142 | Cite as

Infliximab

Basal cell carcinoma and infection: 2 case reports
Case report
  • 12 Downloads

Reference

  1. Greener T, et al. Higher Infliximab Levels Are Not Associated with an Increase in Adverse Events in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 24: 1808-1814, No. 8, Aug 2018. Available from: URL: http://doi.org/10.1093/ibd/izy066 - CanadaCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations